Edwards LifesciencesvsMerck & Company

EW and MRK stock compared: price, dividend, valuation and results, from SEC filings.

EW

Edwards Lifesciences Corporation

$107.11

Value $62.2B

+1.28%
EW's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

+0.55%
MRK's page

Edwards Lifesciences (EW) has a market value of $62.2B and Merck & Company (MRK) $357B. Over the last year, with dividends, EW moved +25.2% and MRK +66.3%. The P/E is 60.9 for EW and 145.6 for MRK. Dividend yield: EW none, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EW$62.2B

    MRK$357B

    MRK is 5.7 times EW

  • Revenue, 12 months

    EW$6.7B

    MRK$67.4B

    MRK is 10 times EW

  • Net income, 12 months

    EW$1.0B

    MRK$2.5B

    MRK is 2.4 times EW

  • Operating margin

    EW21.6%

    MRK–

  • ROIC

    EW9.0%

    MRK3.9%

    5.1 points apart

  • P/E

    EW60.9

    MRK145.6

    MRK is 2.4 times EW

  • Dividend yield

    EW0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    EW-7.6%

    MRK+104.9%

    112.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EW-7.6%

MRK+104.9%

5010015020020222023202420252026
Returns by period
PeriodEWWith dividendsMRKWith dividends
1 year since November 12, 2025+25.2%Price +25.2%+66.3%Price +61.6%
3 years since November 13, 2023+65.9%+18.4% a yearPrice +65.9%+58.0%+16.5% a yearPrice +44.2%
5 years since November 12, 2021-7.6%-1.6% a yearPrice -7.6%+104.9%+15.4% a yearPrice +75.9%
10 years since November 16, 2016+260.7%+13.7% a yearPrice +260.7%+235.5%+12.9% a yearPrice +147.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EWEdwards LifesciencesMRKMerck & Company

Valuation

EWMRK
Valuation
Price$107.11$144.46
Market value$62.2B$357B
Enterprise value (EV)$58.2B$401B
P/E60.9145.6
P/E, 5-year median33.214.8
P/B5.78.0
EV/EBIT40.484.3
Free cash flow yield2.3%4.1%

Results and growth

EWMRK
Results and growth
Revenue, 12 months$6.7B$67.4B
Net income, 12 months$1.0B$2.5B
Free cash flow, 12 months$1.4B$14.7B
Earnings per share, 12 months$1.77$0.98
Revenue growth, year on year11.6%1.3%
Revenue growth a year, past+6.7%over 5 years+9.4%over 5 years
EPS growth a year, past+7.1%over 5 years+21.2%over 5 years

Margins and returns on capital

EWMRK
Margins and returns on capital
Gross margin78.0%71.8%
Operating margin21.6%–
Net margin15.3%3.6%
ROIC9.0%3.9%
ROE9.8%5.2%

Balance sheet

EWMRK
Balance sheet
Cash$4.6B$9.7B
Total debt$705M$53.8B
Net debt / EBITDA-2.55.7
Interest cover70.6×2.4×

Dividends and buybacks

EWMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield1.4%1.4%
Shareholder yield1.4%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EW or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Edwards Lifesciences or Merck & Company?

By market value, Merck & Company ($357B) is about 5.7 times Edwards Lifesciences ($62.2B), at today's prices.

How did EW and MRK stock do over the last 10 years?

Since November 16, 2016, EW's price moved +260.7% and MRK's +147.3%. With dividends: EW +260.7% (+13.7% a year), MRK +235.5% (+12.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, EW or MRK?

The dividend yield at today's price is none for Edwards Lifesciences and 2.35% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of EW and MRK?

At today's price, the P/E is 60.9 for EW and 145.6 for MRK. The median of the last five years was 33.2 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Edwards Lifesciences or Merck & Company?

Over the last twelve months, the net margin was 15.3% for Edwards Lifesciences and 3.6% for Merck & Company, and the operating margin 21.6% and –. Revenue was $6.7B and $67.4B.

Which is the better investment, Edwards Lifesciences or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.